Navigation Links
Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 Supplements
Date:2/11/2013

JERUSALEM, DEXTER, Michigan, February 11, 2013 /PRNewswire/ --

Qualitas Health and Valicor Renewables announced today a strategic partnership that will accelerate the launch of high-EPA Omega-3 oil from algae. The companies have joined forces to combine their expertise and experience in biology, advanced chemistry and technology commercialization to make a significant impact on the global Omega-3 market with next-generation algae based products.

     (Logo: http://photos.prnewswire.com/prnh/20130211/594450-a)

     (Logo: http://photos.prnewswire.com/prnh/20130211/594450-b)

"We are excited to work with Valicor Renewables as our strategic extraction partner" says Dr. Isaac Berzin , CTO of Qualitas Health. "Exclusive access to Valicor's extraction technology gives us a significant technological advantage and reduces the time-to-market of our pure-EPA omega-3 oil from algae. Valicor's technology is proven and practical. It completes the necessary portfolio of technologies needed to manufacture an algae-based Omega-3 supplement on a commercial scale."

"The collaboration between Qualitas and Valicor brings together best-in-class cultivation and strain technology with best-in-class class extraction technology, protected by robust patents" says Dr. Brian Goodall , VP. Business Development at Valicor Renewables. "Valicor's extraction technology is designed to keep the natural algae polar lipids intact while avoiding the use of potentially harmful solvents".

About Qualitas Health:

Qualitas Health is a privately-held company developing high-value vegetarian food supplements and pharmaceutical ingredients based on microalgae. Building on over 10 years' experience in algae cultivation and extraction from the biofuel sector, the company's team has developed a unique and proprietary technology for strain selection, sustainable algae farming, harvesting and oil processing. The technology allows for the effective production of proprietary premium Omega-3 algae oil for a wide range of applications.

http://www.qualitas-health.com

About Valicor Renewables   (formerly SRS Energy):

Headquartered in Dexter, Michigan, Valicor services clients throughout the United States in the automotive, aerospace, alternative fuels, algae-derived products, power generation, and steel industries. The company operates three business groups, Environmental Services, Separation Technologies and Renewables, concentrating on the advancement of its technologies in processes and fluid management to meet client needs.  Since beginning the Algae Extraction Program in 2007, Valicor Renewables has established transformative new techniques for the extraction and fractionation of algae oil.  The development of the patent pending Valicor Algafrac™ technologies has provided for commercially scalable processes which efficiently and cost-effectively extract both polar and non-polar lipids.

http://www.valicor.com

Contact:
Yuri Shoshan
CEO
+972-54-4449991
yshoshan@qualitas-health.com


'/>"/>
SOURCE Qualitas Health Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
2. Trovagene to Present at Leerink Swan Global Healthcare Conference
3. EU Study Finds UK Health Product Benefit Metric Flawed
4. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
5. Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
6. Life Technologies to Present at Leerink Swann Global Healthcare Conference
7. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
8. Nutrex Hawaii Hawaiian Astaxanthin Microalgae May be the Secret to Better Eye Health
9. Providence Health & Services Selects Conflict of Interest Management System
10. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
11. Dr. Alexander Fleming on Searching for Solutions to Metabesity and Healthy Aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... Indiana-based Xylogenics announced ... production and fermentation process. The efficiencies created by the newest strain design ... notably the ethanol industry wherein individual production plants are planning to invest upwards ...
(Date:6/26/2017)... ... ... Two new members were elected to the University City Science Center’s Board ... J Nowak Strategy and Michele Masucci, Ph.D., Vice President for Research Administration at Temple ... Kenneth L. Kring, and re-election of David P. Holveck and Richard P. Jaffe, as ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Academy of Model ... University Aviation Association (UAA), the unifying voice for collegiate aviation education, are launching ... teamwork, competition, and success through a STEM-based education platform. , Much like the ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... designating infertility as a disease, bringing new hope for prospective parents who are ... annual meeting to back the World Health Organization’s designation in hopes of changing ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):